Post-Conference Workshop - Implementing a vaccine clinical development plan in Asia

Post-Conference Workshop - Implementing a vaccine clinical development plan in Asia ›

Post-Conference Workshop - Growing vaccine pipeline value through effective partnering and investment strategies in Asia ›

last modified: 24 May '12

Please enable javascript to see more information on speakers

Effectively implementing a vaccine clinical development plan in Asia

Clinical trials are increasingly being conducted on a global scale to accelerate trial progress with pharma companies facing the loss of patent protection for many of their branded drugs. In addition, the weak pipelines of many pharmas are intensifying the need for accelerated clinical development. With vaccines increasingly seen as one of the most promising sector with huge development potential in the pharmaceutical industry, it is crucial to implement an effective clinical development plan for vaccines in Asia.

Attend this masterclass and learn how to:

• Review the principles of applying Good Clinical Practice (GCP) to a complex clinical development environment especially in global trial programmes
• Learn how a risk management approach to quality management can improve quality practices
• Understand the role of the investigator in accelerating clinical trials
• Develop a strategy for compliant clinical trial supply from planning to execution

Who should attend:

• Clinical research professionals
• Clinical development professionals
• Clinical operations professionals
• Medical affairs professionals
• R&D professionals

Get the World Vaccine Congress Asia 2012 brochure ›

Post-Conference Workshop - Implementing a vaccine clinical development plan in Asia ›

Post-Conference Workshop - Growing vaccine pipeline value through effective partnering and investment strategies in Asia ›

last modified: 24 May '12

Attend ›

the awards

Developing effective production strategies for multi-vaccine manufacturing in Asia

Evaluating specific challenges associated with manufacturing different vaccines
Developing robust approaches to fully utilise production facility
Exploring the different strategies available for ensuring quality control and regulatory compliance

Growing vaccine pipeline value through effective partnering and investment strategies in Asia

Asia contains a wide variety of vaccine markets, each with different advantages due to cultural, economic and geographic differences. Identifying the right partners to develop vaccines from initial R&D through trials to commercialization requires a strategic and well defined approach.
This workshop will assist participants in understanding how to approach the Asian market for external research and development and how to successfully build a pipeline through strategic partnerships.

Transitioning existing biologics processes into single use technology platform to enable global deployment

Factors to consider before implementation: performance equivalency, quality, logistics and business needs
Evaluating which single-use equipment to utilize, considering cost and which stage should be implemented first
Examining before and after implementation for optimum efficiency

Optimising cost-effective Japanese Encephalitis (JE) vaccine development in Asia

Evaluating current development on inactivated and live molecular JE vaccine for the global population
Tapping on lessons learnt from producing the vaccine in Asia
Case study: Assessing the long term immunity of live attenuated Japanese encephalitis chimeric virus vaccine

Innovative vaccine design: Important chemistry, manufacturing and controls (CMC) issues in adjuvant development

Uncovering new concepts and knowledge about innovative vaccine design; innate immunity and beyond
Tapping on advanced technologies of immune-manipulation and delivery system in Japan
Overcoming regulatory hurdles and harnessing the potential for adjuvants in Japan; key factors for very safe and efficacious vaccines

Innovative International Vaccine Developments

Leading global and Asian biotechs, pharmas and research institutes will showcase their latest vaccine developments looking for potential partners globally and across Asia. Potential partnerships run from research and development to licensing and collaboration in vaccine commercialization.

sponsor World Vaccine Congress Asia 2012 ›

Asia'a largest vaccine event